Company: CERO
Filing Date: 2025-11-19
Form Type: 10-Q
Source: 0001213900-25-112619
Chunk: 491

Company: CERO THERAPEUTICS HOLDINGS, INC.
Filing Date: 2025-11-19
Form: 10-Q
Item: Part II, Item 1
Chunk 491
---
 SEC or other regulatory authorities. Moreover, responding to such investigations are likely to consume a significant
amount of our management resources and cause us to incur significant legal and accounting expenses. Failure to remedy any material weakness
in internal control over financial reporting, or to maintain effective control systems, could also restrict our future access to the
capital markets. This could result in an adverse reaction in the financial markets due to a loss of confidence in the reliability of
our financial statements.

As a public reporting
company, we are subject to filing deadlines for reports that we file pursuant to the Exchange Act, and our failure to timely file such
reports may have material adverse consequences on our business.

Following the consummation
of the Business Combination, we failed to timely file our Form 8-K with Form 10 information prior to the “staleness” date
(as determined in accordance with the applicable rules and regulations of the SEC) applicable to the financial statements that were required
by the applicable accounting requirements and other rules and regulations of the SEC to be included in such filing (including pro forma
financial information); thus, we have not remained timely in our reporting requirements with the SEC since we became an SEC reporting
company on February 14, 2024. Although we regained status as a current filer by filing a Form 8-K/A with current financial statements
on April 1, 2024, we were unable to remain timely in our reporting requirements as a result of our failure to file our Quarterly Report
on Form 10-Q for the period ended June 30, 2025 by August 19, 2025, the extended deadline resulting from our filing of a notice on Form
12b-25 on August 15, 2025, as a result, we will not be eligible to file any new registration statement on Form S-3 and, following any
requirement to amend any existing registration statement on Form S-3, including as a result of the updating of such registration statement
pursuant to Section 10(a)(3) of the Securities Act upon the filing of our Annual Report on Form 10-K for the fiscal year ending December
31, 2025, we will not be eligible to use any existing registration statement on Form S-3, in each case, that would allow us to continuously
incorporate by reference our SEC reports into the registration statement, or to use “shelf” registration statements to conduct
offerings, until approximately one year from the date we regained